Evaluation of optimum timing for intravitreal injection of aflibercept for age-related macular degeneration
Phase of Trial: Phase II
Latest Information Update: 30 Mar 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Choroidal neovascularisation
- Focus Therapeutic Use
- 25 Mar 2017 Planned number of patients changed from 100 to 40.
- 01 Nov 2016 Status changed from active, no longer recruiting to completed.
- 18 Jul 2016 Status changed from recruiting to active, no longer recruiting.